{
  "@context": "aku-v2",
  "@type": "treatment",
  "@id": "vasc:wound:hyperbaric-oxygen",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T03:25:00.000Z",
    "updated": "2026-01-07T03:25:00.000Z",
    "contributors": ["knowledge-graph-agent"],
    "confidence": 0.85,
    "status": "pending-quality-check"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/wound-care",
    "type": "adjunctive-therapy",
    "difficulty": "advanced",
    "importance": "moderate"
  },
  "content": {
    "title": "Hyperbaric Oxygen Therapy for Wounds",
    "description": "Use of hyperbaric oxygen as adjunctive wound therapy",
    "key_concepts": [
      {
        "concept": "Mechanism",
        "details": "Increases tissue oxygen tension, promotes angiogenesis, enhances neutrophil killing"
      },
      {
        "concept": "Indications",
        "details": "Diabetic foot ulcers, compromised skin grafts/flaps, chronic refractory osteomyelitis"
      },
      {
        "concept": "Protocol",
        "details": "Typically 2.0-2.4 ATA for 90-120 minutes; 20-40 treatments depending on response"
      },
      {
        "concept": "Evidence",
        "details": "Mixed evidence for diabetic foot ulcers; may reduce amputation in select patients"
      }
    ],
    "clinical_significance": "Consider after failed conventional therapy in appropriate candidates"
  },
  "provenance": {
    "primary_sources": ["Kranke P et al. Cochrane Database Syst Rev 2015"]
  }
}
